Twelve years of assessing the quality of Preimplantation Genetic testing for monogenic disorders [POSTER]

Zandra C. Deans, Anil Biricik, Martine De Rycke, Gary L. Harton, Miroslav Hornak, Farrah Khawaja, Céline Moutou, Jan Traeger-Synodinos, Pamela Renwick. 2022 International Conference on Prenatal Diagnosis and Therapy (ISPD), Montreal, Canada

Expert opinion on NSCLC small specimen biomarker testing part 2: analysis, reporting and quality assessment

Penault-Llorca, F., Kerr, K.M., Garrido, P. et al. Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment. Virchows Arch (2022). https://doi.org/10.1007/s00428-022-03344-1

Expert opinion on NSCLC small specimen biomarker testing part 1: tissue collection and management

Penault-Llorca, F., Kerr, K.M., Garrido, P. et al. Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management. Virchows Arch (2022). https://doi.org/10.1007/s00428-022-03343-2

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer

Fairley, J.A., Cheetham, M.H., Patton, S.J. et al. Results of a worldwide external quality assessment of cfDNA testing in lung Cancer. BMC Cancer 22, 759 (2022). https://doi.org/10.1186/s12885-022-09849-x

An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment.

Fairley, J.A.; Deans, Z.C.; Treacy, R.J.L.; Grieg, E.; Bungartz, K.; Burton, R.; Hayes, J.; Elkin, S.K. An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. J. Mol. Pathol. 2022, 3, 125–139. https://doi.org/10.3390/jmp3030012